Endovenous laser ablation of the great and short saphenous veins with a 1320-nm neodymium:yttrium-aluminum-garnet laser: Retrospective case series of 1171 procedures - 16/01/14
Abstract |
Background |
Venous insufficiency is a common medical condition affecting up to 50.5% of women and 30.1% of men. Endovenous laser ablation is a minimally invasive procedure that safely and effectively treats reflux involving the great and short saphenous veins.
Objective |
We sought to present safety and efficacy data of 1171 endovenous laser ablations using the Scripps Clinic endovenous laser therapy (EVLT) protocol.
Methods |
We conducted an institutional review board–approved, retrospective chart analysis of 1171 endovenous laser ablations performed from March 2007 until February 2011 treated at Scripps Clinic with the 1320-nm neodymium:yttrium-aluminum-garnet laser with 1-month, 6-month, 1-year, and 2-year follow-up data.
Results |
Our current overall experience is greater than 2000 EVLT procedures. The mean follow-up for this case series of 1171 EVLT procedures (1066 great saphenous veins and 105 short saphenous veins) is 11.4 months with an overall closure success rate of 99.9% for patients not lost to follow-up. There has been no incidence of deep vein thrombosis, permanent nerve damage, or pulmonary embolism related to laser ablation.
Limitations |
Retrospective chart analysis, investigator bias, patients lost to follow-up, and lack of quality-of-life assessment are limitations.
Conclusion |
EVLT using a 1320-nm neodymium:yttrium-aluminum-garnet laser appears to be a viable option for venous insufficiency and venous ulceration unresponsive to conservative treatment.
Le texte complet de cet article est disponible en PDF.Key words : CoolTouch laser, endovenous laser ablation, endovenous laser therapy, great saphenous vein, Nd:YAG, short saphenous vein, varicose veins, venous insufficiency, venous ulcers
Abbreviations used : DVT, EVLT, GSV, LTFU, Nd:YAG, SSV
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
|
Dr Moul completed her procedural dermatology fellowship under the direction of Drs Housman and Greenway at Scripps Clinic, where the study data were collected. |
Vol 70 - N° 2
P. 326-331 - février 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?